A study revealed that activating sensory nerves in breast tumors aids cancer growth and spread. Researchers found that using an FDA-approved anti-nausea drug, aprepitant, can disrupt this pathway, potentially halting breast cancer progression in mice and suggesting new treatment possibilities for humans.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing